Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Celgene Corporation (CELG)

-NasdaqGS
118.68 Up 1.02(0.87%) Mar 27, 4:00PM EDT
|After Hours : 118.51 Down 0.17 (0.14%) Mar 27, 7:56PM EDT
Add to Portfolio
Prev Close:117.66
Open:118.11
Bid:118.50 x 100
Ask:118.89 x 1000
1y Target Est:138.43
Beta:1.77
Earnings Date:Apr 22 - Apr 27 (Est.)
Day's Range:118.02 - 120.00
52wk Range:66.85 - 129.06
Volume:5,510,401
Avg Vol (3m):5,397,220
Market Cap:95.01B
P/E (ttm):49.66
EPS (ttm):2.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.87%95.01B
JNJUp 0.20%278.99B

Key Statistics

Forward P/E (1 yr):18.75
P/S (ttm):12.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.82
Quarterly EPS Est (Mar-15) :1.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback